Trials show dupilumab effective, safe for moderate to severe AD
The SOLO 1 and SOLO 2 phase 3 trials of the human monoclonal anti-body dupilumab for the treatment of eczema/atopic dermatitis (AD) have...
top of page
it's where dermatology lives
Featured Posts
bottom of page